Texas Children's as of March 31, 2019
Portfolio Holdings for Texas Children's
Texas Children's holds 24 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Black Stone Minerals (BSM) | 48.7 | $40M | 2.3M | 17.64 | |
| SPDR S&P Oil & Gas Explore & Prod. | 18.0 | $15M | 483k | 30.74 | |
| Enterprise Products Partners (EPD) | 9.1 | $7.5M | 257k | 29.10 | |
| Market Vectors Etf Tr Oil Svcs | 2.8 | $2.3M | 136k | 17.23 | |
| Ascendis Pharma A/s | 2.3 | $1.9M | 16k | 117.67 | |
| Solid Biosciences | 1.6 | $1.3M | 141k | 9.20 | |
| Wave Life Sciences (WVE) | 1.4 | $1.2M | 31k | 38.86 | |
| United Therapeutics Corporation (UTHR) | 1.3 | $1.1M | 9.4k | 117.38 | |
| Beigene | 1.3 | $1.1M | 8.3k | 131.95 | |
| Alexion Pharmaceuticals | 1.2 | $999k | 7.4k | 135.20 | |
| Abiomed | 1.1 | $905k | 3.2k | 285.58 | |
| Genomic Health | 1.0 | $838k | 12k | 70.03 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $817k | 9.2k | 88.79 | |
| Chemocentryx | 1.0 | $808k | 58k | 13.90 | |
| Incyte Corporation (INCY) | 0.9 | $785k | 9.1k | 86.03 | |
| Seattle Genetics | 0.9 | $774k | 11k | 73.25 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $741k | 8.4k | 88.12 | |
| Zogenix | 0.9 | $739k | 13k | 55.03 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $657k | 25k | 26.85 | |
| Array BioPharma | 0.8 | $621k | 26k | 24.37 | |
| Amicus Therapeutics (FOLD) | 0.8 | $620k | 46k | 13.60 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $612k | 64k | 9.51 | |
| Amarin Corporation (AMRN) | 0.7 | $585k | 28k | 20.75 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $492k | 61k | 8.14 |
